drugset / Trial / NCT05526742
A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the relative bioavailability of CKD-510 tablet formulation compared with CKD-510 capsule formulation, and to characterize the effect of food on the CKD-510 tablet.
Timeline
- Start
- 2022-08-24
- Primary completion
- 2022-09-13
- Completion
- 2022-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-510 | Unknown | — | Oral |
Indications
No indication recorded.